EUCTR2013-003822-96-CZ进行中（未招募）1 期
A prospective, multicenter, double-blind, randomized, placebo-controlled, parallel group, 12-week study to evaluate the safety and tolerability of macitentan in subjects with combined pre- and post-capillary pulmonary hypertension (CpcPH) due to left ventricular dysfunction - MELODY-1
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Males and Females >=18 years of age
- •2. Subjects with combined pre-and post-capillary Pulmonary Hypertension (CpcPH) due to left ventricular dysfunction (subset of WHO groups 2.1 and 2.2)
- •3. Optimized diuretic therapy
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 30
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 30
排除标准
- •1. Types of Pulmonary Hypertension other than WHO groups 2.1 and 2.2 (Nice classification)
- •2. Administration of PAH-specific therapy (i.e., Endothelin receptor antagonists (ERAs), Prostanoids, Phosphodiesterase 5 (PDE-5) inhibitors, guanylate cyclase stimulators)
研究者
相似试验
已完成
2 期
A clinical study to estimate the safety, tolerability and efficacy of two medications for treatment of complicated intraabdominal infections in adults.CTRI/2009/091/000084ovexel SA
进行中（未招募）
1 期
Evaluation of the safety of macitentan in patients with pulmonary hypertension due to left heart failure.Combined pre- and post-capillary pulmonary hypertension (CpcPH) due to left ventricular dysfunction.MedDRA version: 16.1Level: LLTClassification code 10024106Term: Left heart failureSystem Organ Class: 100000004849MedDRA version: 16.1Level: PTClassification code 10037400Term: Pulmonary hypertensionSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2013-003822-96-ITActelion Pharmaceuticals Ltd.60
进行中（未招募）
不适用
Evaluation of the safety of macitentan in patients with pulmonary hypertension due to left heart failure.Combined pre- and post-capillary pulmonary hypertension (CpcPH) due to left ventricular dysfunction.MedDRA version: 16.1Level: LLTClassification code 10024106Term: Left heart failureSystem Organ Class: 100000004849MedDRA version: 17.0Level: PTClassification code 10037400Term: Pulmonary hypertensionSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2013-003822-96-BEActelion Pharmaceuticals Ltd.60
进行中（未招募）
不适用
Evaluation of the safety of macitentan in patients with pulmonary hypertension due to left heart failure.EUCTR2013-003822-96-ESActelion Pharmaceuticals Ltd.60
进行中（未招募）
1 期
Addition of low doses of hCG in the rFSH stimulation of infertile women of older age who are undergoing IVFInfertilityEUCTR2016-005208-24-GRProf. Harry Siristatidis100